xarelto makerOur attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so could be grounds for compensation. Our lawyers are functioning difficult to get these hurt by the drug the compensation they may be entitled to.

Even though bleeding is actually a frequent complication linked with anticoagulants, it has been alleged that Xarelto is far more hazardous than conventional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This indicates that, within the event of an emergency, individuals may possibly be at threat for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging.

Should you or possibly a loved a single suffered a severe bleeding event following taking Xarelto, you may have legal recourse. For much more data, speak to us nowadays to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in circumstances of death, funeral costs. Moreover, they may be searching for punitive damages, that are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal http://m.artrosis.pl/ (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

warfarin xareltoVisit this page for a lot more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
이 게시물을..